Target intelligence / Profile preview

Solute carrier family 25 member 43 (SLC25A43)

Target
SLC25A43
Molecular classification
Transporter, Mitochondrial carrier, Solute carrier family (SLC), Inner mitochondrial membrane protein
01

Overview

Solute carrier family 25 member 43 (SLC25A43) is an inner mitochondrial membrane transporter in the SLC25 gene family, which comprises proteins responsible for translocating a variety of metabolites, nucleotides, and cofactors across the mitochondrial inner membrane. The specific substrate transported by SLC25A43 remains unidentified, but it likely influences mitochondrial function, redox status, and cell cycle progression. SLC25A43 functions as a regulator of cell proliferation and is implicated as a tumor suppressor in HER2-positive breast cancer, where it is frequently deleted or epigenetically silenced. Its loss can alter the cell cycle, enhance resistance to oxidative stress, and modulate the efficacy of chemotherapeutic agents such as paclitaxel and trastuzumab. Reduced SLC25A43 expression can enhance antioxidant capacity and promote cancer cell survival under stress conditions, suggesting important roles in both metabolism and cancer biology[2][3][4][5].

Other names
SLC25A43Solute carrier family 25 member 43mitochondrial carrier family member 43
02

Mechanism of action

Modulation of cell susceptibility to cytotoxicity and cell cycle arrest by influencing drug responses (for paclitaxel and trastuzumab)[3]

03

Biological functions

Mitochondrial transportCell cycle regulationCell proliferationRegulation of oxidative stress response
04

Disease associations

Cancer, specifically HER2-positive breast cancerOxidative stress-related pathologies
05

Safety considerations

Potential mitochondrial dysfunction from altered expressionpossible contributions to chemoresistance in cancer
06

Interacting drugs

Paclitaxel

1 more in the full profile.

07

Biomarkers

Epigenetic methylation patternLoss of heterozygosity in HER2-positive breast cancer

Beyond the preview

Go deeper on Solute carrier family 25 member 43 (SLC25A43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 43 (SLC25A43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call